secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0000721371-23-000058
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q4 non-GAAP EPS $1.55 (+48%); raises FY24 guidance to $6.50-$6.75
--------------------------------------------------------------------------------

- Q4 revenue $53.5B (+13% YoY); non-GAAP EPS $1.55 (+48%) vs $1.05 prior year.
- Pharmaceutical segment profit up 12% to $504M; Medical segment profit improved to $82M from -$16M.
- Full-year non-GAAP EPS $5.79 (+14%), an all-time high; operating cash flow $2.8B.
- FY2024 non-GAAP EPS guidance raised to $6.50-$6.75 from $6.45-$6.70; segment profit growth expected.
- Director Carrie S. Cox will not stand for re-election at 2023 annual meeting; no disagreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/0000721371-23-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/cah-20230810.htm
  HTML page:      https://secwatch.observer/filing/0000721371-23-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer